Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia
Background. Aurothioglucose- (ATG-) mediated inhibition of thioredoxin reductase-1 (TXNRD1) improves alveolarization in experimental murine bronchopulmonary dysplasia (BPD). Glutathione (GSH) mediates susceptibility to neonatal and adult oxidative lung injury. We have previously shown that ATG atten...
Main Authors: | Stephanie B. Wall, Rachael Wood, Katelyn Dunigan, Qian Li, Rui Li, Lynette K. Rogers, Trent E. Tipple |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2019/7945983 |
Similar Items
-
Selenium supplementation of lung epithelial cells enhances nuclear factor E2-related factor 2 (Nrf2) activation following thioredoxin reductase inhibition
by: Rachael Tindell, et al.
Published: (2018-10-01) -
Mechanisms of nuclear localization of glutathione reductase, subnuclear colocalization with thioredoxin, and genetic analysis of a chemically induced glutathione reductase knockout
by: Rogers, Lynette K.
Published: (2004) -
Identification of Peptide Antagonists to Thioredoxin Glutathione Reductase of Schistosoma japonicum
by: Li-Jun Song, et al.
Published: (2018-01-01) -
Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase
by: Justin R. Prigge, et al.
Published: (2017-06-01) -
Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase
by: Sonam Gaba, et al.
Published: (2014-01-01)